生物标志物在COVID-19患者的诊断工具中的作用:分层化变得容易
Ahmed Abdallah Salman1, Heba Mohamed Abdallah2, Sami Eldahdouh3
1Internal Medicine Department, Faculty of medicine, Cairo University, Cairo, Egypt.
International journal of general medicine
|October 30, 2024
概括
血清生物标志物如纤维素和介质素-6 (IL6) 可以帮助识别重症冠状病毒病2019 (COVID-19) 病例在重症监护室 (ICU) 入院时. 这些标志物有助于预测患者的结果,并指导治疗策略.
科学领域:
- 医学生物标志物 医学生物标志物
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 新冠病毒病2019 (COVID-19) 呈现的严重程度各不相同.
- 早期识别严重病例对于适当的患者管理至关重要.
- 血清生物标志物是疾病严重程度的潜在指标.
研究的目的:
- 调查各种血清生物标志物在COVID-19患者分类中的作用.
- 为了确定这些生物标志物是否可以在入院时区分严重的COVID-19病例.
主要方法:
- 从COVID-19患者的血液样本中分析了C-反应蛋白 (CRP),D-二次体,纤维素,中性粒细胞-淋巴细胞比率 (NLR),白细胞CRP比率 (LeCR),淋巴细胞-CRP比率 (LCR),互白素-6 (IL6) 等.
- 在第3天和第7天对IL6,费里丁,D-二聚体和tPAI-1进行了随访测量.
- 进行了统计分析,以比较患者组之间的生物标志物水平.
主要成果:
- 高血压,COPD和缺血症被确定为严重的COVID-19的主要危险因素.
- 在患者组之间观察到纤维素,IL6,LeCR和LCR水平的显著差异.
- 这些特定的生物标志物显示出与疾病严重程度的统计学意义上的关联.
结论:
- 在重症监护室 (ICU) 入院的实验室测试结果对于区分严重的COVID-19病例是有价值的.
- 生物标志物分析可以帮助临床医生预测疾病进展和量身定制治疗.
- 通过生物标志物早期识别严重的COVID-19,可以改善患者的护理.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
01:30Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3